Provided by Tiger Trade Technology Pte. Ltd.

Cidara Therapeutics

221.38
0.0000
Volume:- -
Turnover:- -
Market Cap:6.96B
PE:-19.73
High:221.38
Open:221.38
Low:221.38
Close:221.38
52wk High:221.42
52wk Low:15.22
Shares:31.44M
Float Shares:24.87M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.2200
EPS(LYR):-26.7460
ROE:-68.70%
ROA:-29.35%
PB:16.48
PE(LYR):-8.28

Loading ...

Cidara Therapeutics downgraded to Neutral from Overweight at JPMorgan

TIPRANKS
·
Nov 15, 2025

Small U.S. Stocks Finish Mixed As Cidara Therapeutics Leads, Diginex Lags

Dow Jones
·
Nov 15, 2025

Sector Update: Health Care Stocks Ease Late Afternoon

MT Newswires Live
·
Nov 15, 2025

US STOCKS-S&P 500 climbs after selloff; traders look to Nvidia report

Reuters
·
Nov 15, 2025

Cidara Therapeutics Cut to Hold From Buy by Needham

Dow Jones
·
Nov 15, 2025

Needham Downgrades Cidara Therapeutics to Hold From Buy

MT Newswires Live
·
Nov 15, 2025

Cidara Therapeutics (CDTX) was downgraded to a Hold Rating at Needham

TIPRANKS
·
Nov 15, 2025

Top Midday Stories: Merck to Acquire Cidara Therapeutics for $9.2 Billion; Walmart Names John Furner as CEO

MT Newswires Live
·
Nov 15, 2025

HC Wainwright Downgrades Cidara Therapeutics to Neutral From Buy

MT Newswires Live
·
Nov 15, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Molina Healthcare, Memory chip makers, Binah Capital

Reuters
·
Nov 14, 2025

Cidara Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
Nov 14, 2025

Cidara Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
Nov 14, 2025

Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday

Benzinga_recent_news
·
Nov 14, 2025

Stock Track | Cidara Therapeutics Soars Over 105% on $9.2 Billion Merck Acquisition Deal

Stock Track
·
Nov 14, 2025

US STOCKS-Wall Street set to drop as tech selloff extends, rate cut hopes fade

Reuters
·
Nov 14, 2025

Cidara Therapeutics:Co to Pay $300.6 Mln Termination Fee to Merck IF Deal Is Terminated Under Certain Conditions - SEC Filing

THOMSON REUTERS
·
Nov 14, 2025

Cidara Therapeutics Inc - IF Deal Is Terminated Under Some Circumstances, Merck to Pay Fee of $462.4 Mln to Co

THOMSON REUTERS
·
Nov 14, 2025

This Biotech Stock Is Soaring 100%. Merck Is Buying It. -- Barrons.com

Dow Jones
·
Nov 14, 2025

Cidara Therapeutics Stock (CDTX) Rockets on $9B Merck (MRK) Deal

TIPRANKS
·
Nov 14, 2025

Merck Shares Down 1.5% Premarket After Co to Buy Cidara Therapeutics for $9.2 Bln

THOMSON REUTERS
·
Nov 14, 2025